99% Purity CAS 763113-22-0 Olaparib Antineoplastic Olaparib Powder Pharmaceutical Intermediate Olaparib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Olaparib
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Olaparib
• Name: Olaparib Powder
• Appearance: White or off-White Crystalline Powder
• Color: White or off-White Color
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 763113-22-0
• Mf: C24h23fn4o3
• MW: 434.46300
• Density: 1.43
• Refractive Index: 1.702
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 1 Ton/Month

Product Description

99% Purity CAS 763113-22-0 Olaparib Antineoplastic Olaparib Powder Pharmaceutical Intermediate Olaparib

Product Description

 

Product Details

Product Name	Olaparib
Appearance	White or off-white crystalline powder
CAS No.	763113-22-0
MF	C24H23FN4O3
MW	434.46300

Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair.Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy.

Application & Function

Function
Olaparib as a maintenance therapy or monotherapy for the treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. On January 12, 2018, FDA expanded the approved use of Olaparib to include chemotherapy-experienced patients with germline breast cancer susceptibility gene (BRCA) mutated, human epidermal receptor 2 (HER2)-negative metastatic breast cancer.
Applications:
Olaparib is an anti-tumor targeted therapy drug, which kills cancer cells mainly by synthesizing a lethal mechanism.It is mainly used clinically for the treatment of advanced epithelial ovarian cancer.

Specification